Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPLOSIVE: Predictive Value of 99mTc-labeled Albumin Spheres for 90Y SIR Spheres Distribution
NCT01186263Phase 2Completed
- Sponsor
- University of Magdeburg
- Start
- Jul 2010
- Primary completion
- Jul 2011
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of technetium Tc 99m macroaggregated albumin, technetium-99m-labeled albumin microspheres in colorectal cancer (CRC), sponsored by University of Magdeburg. Started Jul 2010; status: completed.
02
Drugs
technetium Tc 99m macroaggregated albumintechnetium-99m-labeled albumin microspheres
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01186263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01186263.